
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs.
Ashley Gallagher is an assistant managing editor at Drug Topics®. She graduated in 2020 in journalism and mass communications and received her master’s degree in 2025 in digital journalism from St. Bonaventure University. Previously, she worked as a pharmacy technician for a retail chain.

Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs.

Results show consistent improvements in wakefulness, cataplexy, and quality of life with oveporexton for patients with narcolepsy.

The trial found that up to 25 days of nirmatrelvir-ritonavir did not improve cognitive, autonomic, or exercise-related symptoms compared with placebo.

James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.

ACIP changes, new court rulings, and coverage gaps threaten vaccines, pharmacists’ reimbursement, and children's access through Vaccine For Children.

The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.

Adults with serious mental illness receive GLP-1 prescriptions at rates similar to or higher than their peers, though schizophrenia continued to lag.

A study found that age and physical comorbidities—not psychiatric diagnosis—were associated with nonpsychotropic polypharmacy.

The expert explains 2025-1016 flu, COVID-19, and RSV vaccine updates from AAP, ACOG, AAFP, and IDSA, and what changing schedules mean for pharmacists.

An analysis found all-cause pneumonia Black, lower-income, and medically at-risk children still face substantially higher rates of hospitalization.

Data show postmenopausal women using hormone replacement therapy may have a 10% lower risk of developing dementia.

The approval extends the medication to a younger pediatric population, marking the first FDA-approved treatment for children with this immunodeficiency.

A cross-sectional survey links chronic fatigue, cognitive impairment, and menstrual irregularity to COVID-19 vaccination, with rates differing by brand.

A review of hospitalized patients with COVID-19 links female sex, severe acute illness, and intensive care unit admission to higher odds of long COVID.

Adults with type 1 diabetes who used Omnipod 5 Automated Insulin Delivery System maintained significant improvements in time in range and hemoglobin A1C.

A Bayesian meta-analysis finds patients regain half their treatment-associated weight loss within about 7.5 months of stopping semaglutide or tirzepatide.

AD109 significantly reduces breathing interruptions in adults with obstructive sleep apnea who could not tolerate or had refused CPAP therapy.

A population-level analysis finds that age, comorbidity burden, and long-term care residence continue to drive severe outcomes.

The combination outperformed ixekizumab alone on skin, joint, and weight outcomes through 52 weeks.

Data shows that those who stayed on tirzepatide had monthly health care costs well below those of untreated adults.

Pharmacy technician, Sharon Lucas, showcases how community pharmacy, clinical skills, and lifelong learning are transforming patient care.

Data show adults who received the recombinant shingles vaccine had a lower cardiovascular burden than those who received the discontinued live vaccine.

Data show women are more likely to develop mental health disorders with type 2 diabetes, and men are more likely to develop cardiovascular disease.

New recommendations from the American Academy of Neurology and American Headache Society give providers clearer criteria for preventive migraine therapy.

As data reframes vaccines as a lifelong tool, pharmacists are becoming the access point that keeps patients up to date at every stage of life.

Community pharmacists use a quick migraine toolkit to spot symptoms early, guide OTC care, and refer patients, aiming to prevent chronic migraines.

Independent pharmacist Tom DePietro explains how shifting vaccine policies, ACIP changes, and patient confusion are reshaping immunization at the pharmacy counter.

A new migraine toolkit helps community pharmacists spot underserved patients, tackle racial diagnosis gaps, and connect Black adults to care.

Kelly Goode examines 2026–27 vaccine guidance for pharmacists, detailing updated flu, COVID-19, and RSV recommendations and coadministration.

Live attenuated influenza vaccine increased pneumococcal density in vaccinated children, raising odds of pneumococcal infection among household contacts.